Perspective on the Budgetary Impact of FP/FORM pMDI on Treatment and Management of Exacerbation in Moderate-to-Severe Asthma Patients in Singapore

References

• To T, Stanojevic S, Moores G, et al. Global asthma prevalence in adults: findings from the cross-sectional world health survey. BMC Public Health. 2012;12(1):204. doi:10.1186/1471-2458-12-204
   PubMed Web of Science ®Google Scholar
• Hay SI. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1211–1259.
   PubMed Web of Science ®Google Scholar
• Masoli M, Fabian D, Holt S, Beasley R. The global burden of asthma: executive summary of the GINA dissemination committee report. Allergy. 2004;59(5):469–478. doi:10.1111/j.1398-9995.2004.00526.x
   PubMed Web of Science ®Google Scholar
• Global Strategy for Asthma Management and Prevention, 2019 [homepage on the Internet]. Global initiative for asthma; 2019. Available from: https://ginasthma.org/. Accessed September 1, 2019.
   Google Scholar
• Papi A, Mansur AH, Pertseva T, et al. Long-term fluticasone propionate/formoterol fumarate combination therapy is associated with a low incidence of severe asthma exacerbations. J Aerosol Med Pulm Drug Deliv. 2016;29(4):346–361. doi:10.1089/jamp.2015.1255
   PubMed Web of Science ®Google Scholar
• Gold LS, Yeung K, Smith N, Allen-Ramey FC, Nathan RA, Sullivan SD. Asthma control, cost and race: results from a national survey. J Asthma. 2013;50(7):783–790. doi:10.3109/02770903.2013.795589
   Web of Science ®Google Scholar
• Accordini S, Corsico AG, Braggion M, et al. The cost of persistent asthma in Europe: an international population-based study in adults. Int Arch Allergy Immunol. 2013;160(1):93–101.
   PubMed Web of Science ®Google Scholar
• Doz M, Chouaid C, Com-Ruelle L, et al. The association between asthma control, health care costs, and quality of life in France and Spain. BMC Pulm Med. 2013;13(1):15. doi:10.1186/1471-2466-13-15
   PubMed Web of Science ®Google Scholar
• de Miguel-diez J, Jimenez-Garcia R, Hernandez-Barrera V, et al. National trends in hospital admissions for asthma exacerbations among pediatric and young adult population in Spain (2002–2010). Respir Med. 2014;108(7):983–991. doi:10.1016/j.rmed.2014.04.008
   Web of Science ®Google Scholar
• Bodzenta-Lukaszyk A, Buhl R, Balint B, Lomax M, Spooner K, Dissanayake S. Fluticasone/formoterol combination therapy versus budesonide/formoterol for the treatment of asthma: a randomized, controlled, non-inferiority trial of efficacy and safety. J Asthma. 2012;49(10):1060–1070. doi:10.3109/02770903.2012.719253
   PubMedGoogle Scholar
• Bodzenta-Lukaszyk A, Dymek A, McAulay K, Mansikka H. Fluticasone/formoterol combination therapy is as effective as fluticasone/salmeterol in the treatment of asthma, but has a more rapid onset of action: an open-label, randomized study. BMC Pulm Med. 2011;11(1):28. doi:10.1186/1471-2466-11-28
   PubMed Web of Science ®Google Scholar
• Aalbers R, Brusselle G, McIver T, Grothe B, Bodzenta-Lukaszyk A. Onset of bronchodilation with fluticasone/formoterol combination versus fluticasone/salmeterol in an open-label, randomized study. Adv Ther. 2012;29(11):958–969. doi:10.1007/s12325-012-0058-0
   PubMed Web of Science ®Google Scholar
• Lim D, Small I, Wolfe S, et al. Real world effectiveness of changing fixed-dose combination therapy from seretide MDI to flutiform in UK asthma patients. Oral Presentation presented at: 7th World Conference of the International Primary Care; 2014; Athens, Greece.
   Google Scholar
• Lim D, Small I, Wolfe S, et al. Effectiveness of fluticasone-propionate/salmeterol vs fluticasone-propionate/formoterol in UK patients with asthma. Pragmat Obs Res. 2015;6:34–35.
   Google Scholar
• Usmani OS, Kemppinen A, Gardener E, et al. A randomized pragmatic trial of changing to and stepping down fluticasone/formoterol in asthma. J Allergy Clin Immunol Pract. 2017;5(5):1378–1387.e1375. doi:10.1016/j.jaip.2017.02.006
   PubMed Web of Science ®Google Scholar
• Schmidt O, Petro W, Hoheisel G, Kanniess F, Oepen P, Langer-Brauburger B. Real-life effectiveness of asthma treatment with a fixed-dose fluticasone/formoterol pressurised metered-dose inhaler - results from a non-interventional study. Respir Med. 2017;131:166–174. doi:10.1016/j.rmed.2017.08.017
   PubMed Web of Science ®Google Scholar
• Backer V, Ellery A, Borzova S, et al. Non-interventional study of the safety and effectiveness of fluticasone propionate/formoterol fumarate in real-world asthma management. Ther Adv Respir Dis. 2018;12:1753466618796987. doi:10.1177/1753466618796987
   Web of Science ®Google Scholar
• Martínez-Moragón E, Delgado J, Ojeda P, et al. Economic evaluation of fluticasone propionate/formoterol fumarate (flutiform®) vs fluticasone/salmeterol and budesonide/formoterol in Spain. Value Health. 2015;18(7):A501. doi:10.1016/j.jval.2015.09.1417
   Web of Science ®Google Scholar
• Farrington E, Saunders A, Heron L, Dunlop W. FP/FORM versus FP/SAL within clinical practice: an updated budget impact analysis in asthma. Adv Ther. 2016;33(5):794–806. doi:10.1007/s12325-016-0317-6
   PubMed Web of Science ®Google Scholar
• The Global Asthma Report 2014 [homepage on the Internet]. The global asthma network; 2014. Available from: http://www.globalasthmareport.org/2014/about/executive.php. Accessed September 1, 2019.
   Google Scholar
• Koh MS, Yii AC, Ong YY. Asthma in Singapore: past, present and future. Ann Acad Med Singapore. 2017;46(3):81–83.
   PubMed Web of Science ®Google Scholar
• Mundipharma Singapore Holding Pte Limited. Flutiform^® Pressurised Inhalation, Suspension [Prescribing Information]. Singapore: Mundipharma Singapore Holding Pte Limited; 2014.
   Google Scholar
• Drug Subsidies & Schemes [Homepage on the Internet]. Singapore: Ministry of Health; 2020. Available from: https://www.moh.gov.sg/cost-financing/healthcare-schemes-subsidies/drug-subsidies-schemes. Accessed March 1, 2020.
   Google Scholar
• Boisseau S, Qasuri M, Ho WT, et al. Analysis of the inclusion of fluticasone propionate/formoterol on a government subsidy list in Singapore for the treatment of moderate-to-severe asthma. Value Health. 2018;21:S103–S104. doi:10.1016/j.jval.2018.07.785
   Web of Science ®Google Scholar
• IQVIA data on file. Singapore National Sales 2016–2018 (R03F); 2019.
   Google Scholar
• AstraZeneca Pte Ltd. Symbicort^® Turbuhaler^® Inhalation Powder [Prescribing Information]. Singapore: AstraZeneca Pte Ltd; 2017.
   Google Scholar
• Tan NC, Nguyen HV, Lye WK, Sankari U, Nadkarni NV. Trends and predictors of asthma costs: results from a 10-year longitudinal study. Eur Respir J. 2016;47(3):801–809. doi:10.1183/13993003.00188-2015
   Web of Science ®Google Scholar
• Price D, Fletcher M, van der Molen T. Asthma control and management in 8000 European patients: the REcognise Asthma and LInk to Symptoms and Experience (REALISE) survey. NPJ Prim Care Respir Med. 2014;24(1):14009. doi:10.1038/npjpcrm.2014.9
   PubMed Web of Science ®Google Scholar
• Nguyen HV, Bose S, Mital S, et al. Is bronchial thermoplasty cost-effective as treatment for problematic asthma patients? Singapore’s perspective on a global model. Respirology. 2017;22(6):1102–1109. doi:10.1111/resp.13027
   PubMed Web of Science ®Google Scholar
• Fee Benchmarks and Bill Amount Information [hompeage on the Internet]. Singapore: Ministry of Health; 2019. Available from: https://www.moh.gov.sg/cost-financing/fee-benchmarks-and-bill-amount-information. Accessed January 20, 2019.
   Google Scholar
• Charges & Payment [homepage on the Internet]. Singapore: National University Hospital; 2019. Available from: https://www.nuh.com.sg/patients-visitors/Pages/Charges-Payment.aspx. Accessed September 9, 2020. 20, 2019.
   Google Scholar
• Hospital Charges [homepage on the Internet]. Singapore: Changi General Hospital; 2019. Available from: https://www.cgh.com.sg/patients-visitors/Pages/Hospital-Charges.aspx. Accessed January 20, 2019.
   Google Scholar
• Outpatient Charges [homepage on the Internet]. Singapore: Singapore General Hospital: SingHealth; 2019. Available from: https://www.sgh.com.sg/patient-care/visiting-specialist/Pages/charges-payments.aspx. Accessed January 20, 2019.
   Google Scholar
• Outpatient Charges [homepage on the Internet]. Singapore: Tan Tock Seng Hospital; 2019. Available from: https://www.ttsh.com.sg/Patients-and-Visitors/Your-Clinic-Visit/Pages/Outpatient-Charges.aspx. Accessed January 20, 2019.
   Google Scholar
• Charges & Payment [hompage on the Internet]. Singapore: SingHealth Polyclinics; 2019. Available from: https://polyclinic.singhealth.com.sg/patient-care/charges-payment. Accessed January 20, 2019.
   Google Scholar
• Iwanaga T, Kozuka T, Nakanishi J, et al. Aerosol deposition of inhaled corticosteroids/long-acting β2-agonists in the peripheral airways of patients with asthma using functional respiratory imaging, a novel imaging technology. Pulm Ther. 2017;3(1):219–231. doi:10.1007/s41030-017-0036-4
   Google Scholar
• Hamill J, and Spyridon M. Real-world evidence on asthma review and change from fluticasone propionate/salmeterol to fluticasone propionate/formoterol. Poster presented at: Primary Care Respiratory Society UK Conference 2014; 2014; Leicestershire, UK.
   Google Scholar
• National Health Survey 2010 [homepage on the Internet]. Singapore: Ministry of Health Epidemiology and Disease Control Division; 2011. Available from: https://www.moh.gov.sg/resources-statistics/reports/national-health-survey-2010. Accessed January 20, 2019.
   Google Scholar
• Demoly P, Annunziata K, Gubba E, Adamek L. Repeated cross-sectional survey of patient-reported asthma control in Europe in the past 5 years. Eur Respir Rev. 2012;21(123):66–74. doi:10.1183/09059180.00008111
   PubMedGoogle Scholar
• Price D, David-Wang A, Cho SH, et al. Time for a new language for asthma control: results from REALISE Asia. J Asthma Allergy. 2015;8:93–103.
   PubMed Web of Science ®Google Scholar
• Price D, Musgrave SD, Shepstone L, et al. Leukotriene antagonists as first-line or add-on asthma-controller therapy. N Engl J Med. 2011;364:1695–1707.
   PubMed Web of Science ®Google Scholar
• Global Strategy for Asthma Management and Prevention, 2017 [homepage on the Internet]. Global initiative for asthma; 2017. Available from: https://ginasthma.org/2017-gina/. Accessed January 20, 2019.
   Google Scholar
• Annual Report 2017 [homepage on the Internet]. Singapore: Ministry of Health; 2017. Available from: https://www.moh.gov.sg/resources-statistics. Accessed September 1, 2019.
   Google Scholar
• GlaxoSmithKline Pte Ltd. Seretide® Accuhaler® (salmeterol/fluticasone propionate) inhalation powder [prescribing information]. Singapore: GlaxoSmithKline Pte Ltd; 2016.
   Google Scholar
• GlaxoSmithKline Pte Ltd. Seretide® Evohaler® (salmeterol/fluticasone propionate) inhalation aerosol [prescribing information]. Singapore: GlaxoSmithKline Pte Ltd; 2016.
   Google Scholar
• Kaiser K. and Pertseva T. Long-term safety and efficacy of fluticasone propionate/formoterol fumarate combination therapy in patients with asthma. Prim Care Respir J. 2013;22:A1–A18.
   Google Scholar
• Mansur AH, and Kaiser K. Long-term safety and efficacy of fluticasone/formoterol combination therapy in asthma. J Aerosol Med Pulm Drug Deliv. 2013;26(4):190–199. doi:10.1089/jamp.2012.0977
   Web of Science ®Google Scholar
• Lasserson TJ, Ferrara G, and Casali L. Combination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for chronic asthma in adults and children. Cochrane Database Syst Rev. 2011;12. doi:10.1002/14651858.CD004106
   Google Scholar
• Ducharme FM, Ni Chroinin M, Greenstone I, and Lasserson TJ. Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthma. Cochrane Database Syst Rev. 2010;4. doi:10.1002/14651858.CD005533
   Web of Science ®Google Scholar
• Chauhan BF, and Ducharme FM. Addition to inhaled corticosteroids of long-acting beta2 agonists versus antileukotrienes for chronic asthma. Cochrane Database Syst Rev. 2014;1. doi:10.1002/14651858.CD003137.pub5
   Web of Science ®Google Scholar